The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome.

Saved in:
Bibliographic Details
Title: The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome.
Authors: Ally MS; Department of Dermatology, Stanford University, Redwood City, California., Tang JY; Department of Dermatology, Stanford University, Redwood City, California., Joseph T; Department of Radiology, Stanford University, Redwood City, California., Thompson B; Herbert Irving Comprehensive Cancer Center, Department of Dermatology, Columbia University Medical Center, New York, New York., Lindgren J; Children's Hospital Oakland Research Institute, Oakland, California., Raphael MA; Children's Hospital Oakland Research Institute, Oakland, California., Ulerio G; Herbert Irving Comprehensive Cancer Center, Department of Dermatology, Columbia University Medical Center, New York, New York., Chanana AM; Children's Hospital Oakland Research Institute, Oakland, California., Mackay-Wiggan JM; Herbert Irving Comprehensive Cancer Center, Department of Dermatology, Columbia University Medical Center, New York, New York., Bickers DR; Herbert Irving Comprehensive Cancer Center, Department of Dermatology, Columbia University Medical Center, New York, New York., Epstein EH Jr; Children's Hospital Oakland Research Institute, Oakland, California.
Source: JAMA dermatology [JAMA Dermatol] 2014 May; Vol. 150 (5), pp. 542-5.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2013.7444